Antimicrobial Agents and Chemotherapy Journal

Overview
Identity
View All

publication venue for

Correction for Shelton et al., "Deletion of Rv2571c Confers Resistance to Arylamide Compounds in Mycobacterium tuberculosis".. 66:e0096222-e00922. 2022
Antimicrobial Resistance Hidden within Multiserovar Salmonella Populations.. 65:e00048-e00021. 2021
Emergence of two AcrB substitutions conferring multidrug resistance to Salmonella spp.. 65:AAC.01589-AAC.01520. 2021
Mutations in fbiD (Rv2983) as a Novel Determinant of Resistance to Pretomanid and Delamanid in Mycobacterium tuberculosis.. 65:e01948-e01920. 2020
Chromosomal Resistance to Metronidazole in Clostridioides difficile Can Be Mediated by Epistasis between Iron Homeostasis and Oxidoreductases.. 64:e00415-e00420. 2020
Formulation, Pharmacological Evaluation, and Efficacy Studies of Occidiofungin, a Novel Antifungal.. 64:e01737-e01720. 2020
Novel Antiparasitic Activity of the Antifungal Lead Occidiofungin.. 64:e00244-e00220. 2020
Inhibition of CorA-Dependent Magnesium Homeostasis Is Cidal in Mycobacterium tuberculosis.. 63:e01006-e01019. 2019
3-O-Methyl-Alkylgallates Inhibit Fatty Acid Desaturation in Mycobacterium tuberculosis.. 63:e00136-e00119. 2019
A Novel Actin Binding Drug with In Vivo Efficacy.. 63:e01585-aac.01518. 2019
Emergence of Resistance to Macrolides and Rifampin in Clinical Isolates of Rhodococcus equi from Foals in Central Kentucky, 1995 to 2017.. 63:aac.01714-aac.01718. 2019
Antimicrobial Activity of Ibuprofen against Cystic Fibrosis-Associated Gram-Negative Pathogens.. 62:e01574-e01517. 2018
Efficacious Analogs of the Lantibiotic Mutacin 1140 against a Systemic Methicillin-Resistant Staphylococcus aureus Infection.. 62:aac.01626-aac.01618. 2018
Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis.. 61:e01334-e01317. 2017
Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection.. 61:e00954-e00917. 2017
Susceptibility of Mycobacterium tuberculosis Cytochrome bd Oxidase Mutants to Compounds Targeting the Terminal Respiratory Oxidase, Cytochrome c.. 61:e01338-e01317. 2017
A Novel 6-Benzyl Ether Benzoxaborole Is Active against Mycobacterium tuberculosis In Vitro.. 61:e01205-e01217. 2017
Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase.. 60:6271-6280. 2016
Rifamycin Resistance in Clostridium difficile Is Generally Associated with a Low Fitness Burden.. 60:5604-5607. 2016
Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis.. 60:4590-4599. 2016
Extended-Spectrum-Cephalosporin Resistance Genes in Escherichia coli from Beef Cattle.. 60:1162-1163. 2016
Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of Caseum.. 60:735-743. 2016
Imidazolium salts as small-molecule urinary bladder exfoliants in a murine model.. 59:5494-5502. 2015
Effects of surotomycin on Clostridium difficile viability and toxin production in vitro.. 59:4199-4205. 2015
A novel antimycobacterial compound acts as an intracellular iron chelator.. 59:2256-2264. 2015
Age-Stratified Treatment Response Rates in Hospitalized Patients with Clostridium difficile Infection Treated with Metronidazole.. 59:6113-6116. 2015
Structure, activity, and inhibition of the Carboxyltransferase -subunit of acetyl coenzyme A carboxylase (AccD6) from Mycobacterium tuberculosis.. 58:6122-6132. 2014
Evaluation of PD 404,182 as an anti-HIV and anti-herpes simplex virus microbicide.. 58:687-697. 2014
Caprine abscess model of tulathromycin concentrations in interstitial fluid from tissue chambers inoculated with Corynebacterium pseudotuberculosis following subcutaneous or intrachamber administration.. 57:6295-6304. 2013
Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes.. 57:2571-2581. 2013
Arrested protein synthesis increases persister-like cell formation.. 57:1468-1473. 2013
blaCTX-M-32 on an IncN plasmid in Escherichia coli from beef cattle in the United States.. 57:1096-1097. 2013
Both fidaxomicin and vancomycin inhibit outgrowth of Clostridium difficile spores.. 57:664-667. 2013
The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections.. 56:3758-3766. 2012
Sublimable C5A delivery provides sustained and prolonged anti-HIV microbicidal activities.. 56:3336-3343. 2012
PD 404,182 is a virocidal small molecule that disrupts hepatitis C virus and human immunodeficiency virus.. 56:672-681. 2012
MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212.. 56:324-331. 2012
Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.. 55:4631-4638. 2011
Novel inhibitors of InhA efficiently kill Mycobacterium tuberculosis under aerobic and anaerobic conditions.. 55:3889-3898. 2011
Analysis of PBP5 of early U.S. isolates of Enterococcus faecium: sequence variation alone does not explain increasing ampicillin resistance over time.. 55:3272-3277. 2011
Efficacy of antimicrobial peptoids against Mycobacterium tuberculosis.. 55:3058-3062. 2011
Structure of the Mycobacterium tuberculosis D-alanine:D-alanine ligase, a target of the antituberculosis drug D-cycloserine.. 55:291-301. 2011
Mycobacterium tuberculosis dihydrofolate reductase is not a target relevant to the antitubercular activity of isoniazid.. 54:3776-3782. 2010
Pretreatment of epithelial cells with rifaximin alters bacterial attachment and internalization profiles.. 54:388-396. 2010
Evaluation of analogs of reutericyclin as prospective candidates for treatment of staphylococcal skin infections.. 53:4028-4031. 2009
In vitro and murine efficacy and toxicity studies of nebulized SCC1, a methylated caffeine-silver(I) complex, for treatment of pulmonary infections.. 53:3285-3293. 2009
Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle.. 50:2912-2918. 2006
Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics.. 50:2762-2771. 2006
Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents.. 49:4821-4833. 2005
Application of quantitative real-time reverse transcription-PCR in assessing drug efficacy against the intracellular pathogen Cryptosporidium parvum in vitro.. 49:4437-4442. 2005
Vancomycin-resistant Enterococcus faecium strains isolated from community wastewater from a semiclosed agri-food system in Texas.. 49:4382-4385. 2005
Altered NADH/NAD+ ratio mediates coresistance to isoniazid and ethionamide in mycobacteria.. 49:708-720. 2005
Analysis of mupirocin resistance and fitness in Staphylococcus aureus by molecular genetic and structural modeling techniques.. 48:4366-4376. 2004
Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90.. 47:2208-2216. 2003
Inhibitors of pantothenate kinase: novel antibiotics for staphylococcal infections.. 47:2051-2055. 2003
Doxycycline induces expression of P glycoprotein in MCF-7 breast carcinoma cells.. 46:755-761. 2002
Mycobacterium smegmatis D-Alanine Racemase Mutants Are Not Dependent on D-Alanine for Growth.. 46:47-54. 2002
Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells.. 36:982-988. 1992
Reduced parasitemia observed with erythrocytes containing inositol hexaphosphate.. 32:391-394. 1988
Use of a Fluorescence-Based Assay To Measure Escherichia coli Membrane Potential Changes in High Throughput.. 64:e00910-e00920.
Mode of action and bactericidal properties of surotomycin against growing and nongrowing Clostridium difficile. 2015